(Q34086102)

30 July 2017

1 reference

title

Comparative tolerability of treatments for inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

30 July 2017

0 references

inflammation

0 references

author name string

R B Stein

series ordinal

1

1 reference

PubMed ID

11085348

30 July 2017

S B Hanauer

series ordinal

2

1 reference

30 July 2017

1 November 2000

1 reference

30 July 2017

1 reference

30 July 2017

23

1 reference

30 July 2017

5

1 reference

30 July 2017

429-448

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200023050-00006

30 July 2017

0 references

cites work

Safe use of glucocorticoids. How to monitor patients taking these potent agents

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200023050-00006

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200023050-00006

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200023050-00006

Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression

21 January 2018

1 reference

12 December 2020

Review article: the medical management of Crohn's disease

1 reference

12 December 2020

Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease

1 reference

12 December 2020

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

1 reference

12 December 2020

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

1 reference

12 December 2020

Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature

1 reference

12 December 2020

Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid

1 reference

12 December 2020

Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

1 reference

12 December 2020

Nonassociation of Adrenocorticosteroid Therapy and Peptic Ulcer

1 reference

12 December 2020

Is atherosclerosis a complication of long-term corticosteroid treatment?

1 reference

12 December 2020

Lymphoma in inflammatory bowel disease

1 reference

12 December 2020

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1 reference

12 December 2020

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

1 reference

12 December 2020

Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome

1 reference

12 December 2020

Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development

1 reference

12 December 2020

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

12 December 2020

Pituitary-adrenal function during corticosteroid therapy. Learning to live with uncertainty.

1 reference

12 December 2020

Pregnancy in organ transplant recipients

1 reference

12 December 2020

Methotrexate for chronic diseases in adults

1 reference

12 December 2020

Safety of azathioprine in pregnancy in inflammatory bowel disease

1 reference

12 December 2020

Idiopathic pancreatitis associated with inflammatory bowel disease

1 reference

12 December 2020

Azathioprine: state of the art in inflammatory bowel disease

1 reference

12 December 2020

Azulfidine agranulocytosis with bone marrow, megakaryocytosis, histiocytosis and plasmacytosis.

1 reference

12 December 2020

Raynaud's phenomenon induced by sulphasalazine

1 reference

12 December 2020

Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application

1 reference

12 December 2020

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience

1 reference

12 December 2020

Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells

1 reference

12 December 2020

Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease

1 reference

12 December 2020

INFECTIOUS COMPLICATIONS OCCURRING IN LIVER TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL

1 reference

12 December 2020

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

1 reference

12 December 2020

Hepatobiliary complications of cyclosporine therapy following renal transplantation

1 reference

12 December 2020

Inflammatory bowel disease and smoking--a review

1 reference

12 December 2020

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

1 reference

12 December 2020

Steroid myopathy. Insidious cause of muscle weakness

1 reference

12 December 2020

Hepatotoxicity of 6-mercaptopurine in Crohn's disease

1 reference

12 December 2020

Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease

1 reference

12 December 2020

Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases

1 reference

12 December 2020

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

1 reference

12 December 2020

Newer treatments for inflammatory bowel disease

1 reference

12 December 2020

Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases

1 reference

12 December 2020

Effects of cyclosporine or FK506 in chronic colitis

1 reference

12 December 2020

Prednisone side-effects and serum-protein levels. A collaborative study

1 reference

12 December 2020

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

1 reference

12 December 2020

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

12 December 2020

Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease

1 reference

12 December 2020

1 reference

12 December 2020

Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine

1 reference

12 December 2020

Lung disease associated with orally administered mesalamine for ulcerative colitis

1 reference

12 December 2020

Cyclosporin for severe ulcerative colitis: a user's guide

1 reference

12 December 2020

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

1 reference

12 December 2020

Selective Erythroid and Megakaryocytic Aplasia After Sulfasalazine Administration

1 reference

12 December 2020

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

1 reference

12 December 2020

Sulfasalazine-induced pulmonary disease

1 reference

12 December 2020

Prednisolone disposition and protein binding in oral contraceptive users

1 reference

12 December 2020

Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects

1 reference

12 December 2020

Renographic monitoring of renal function in patients with Crohn's disease treated with low dose cyclosporin: a controlled study

1 reference

12 December 2020

Neutropenia and thrombocytopenia in renal allograft recipients treated with trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

1 reference

12 December 2020

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

12 December 2020

National transplantation Pregnancy Registry--outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients

1 reference

12 December 2020

Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis

1 reference

12 December 2020

Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease

1 reference

12 December 2020

Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group

1 reference

12 December 2020

Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution

1 reference

12 December 2020

Mechanisms of action of new immunosuppressive drugs.

1 reference

12 December 2020

Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease

1 reference

12 December 2020

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

1 reference

12 December 2020

Bone mineral metabolism in pediatric inflammatory bowel disease

1 reference

12 December 2020

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans

1 reference

12 December 2020

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

12 December 2020

Risk of infectious complications in patients taking glucocorticosteroids

1 reference

12 December 2020

Methotrexate in psoriasis: revised guidelines

1 reference

12 December 2020

Azathioprine suppresses the mixed lymphocyte reaction of patients with Lesch-Nyhan syndrome

1 reference

12 December 2020

Cytotoxic effects of 6-mercaptopurine on the limb-bud blastemal cells of rat embryos

1 reference

12 December 2020

Review article: Drug development in inflammatory bowel disease: budesonide--a model of targeted therapy.

1 reference

12 December 2020

Antibiotics are not effective therapy for Crohn's disease (time to remove the rose-coloured glasses)

1 reference

12 December 2020

Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel Disease

1 reference

12 December 2020

Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night

1 reference

12 December 2020

Prenatal use of metronidazole and birth defects: no association

1 reference

12 December 2020

Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease

1 reference

12 December 2020

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

1 reference

12 December 2020

Review article: osteoporosis, corticosteroids and inflammatory bowel disease.

1 reference

12 December 2020

Glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease

1 reference

12 December 2020

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

1 reference

12 December 2020

Combination ciprofloxacin and metronidazole for active Crohn's disease

1 reference

12 December 2020

The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome

1 reference

12 December 2020

Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine

1 reference

12 December 2020

Azathioprine teratogenicity: review of the literature and case report

1 reference

12 December 2020

Clinical Complications of Corticosteroid Therapy: A Selected Review

1 reference

12 December 2020

Methotrexate therapy of tubal pregnancy

1 reference

12 December 2020

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients

1 reference

12 December 2020

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

1 reference

12 December 2020

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

12 December 2020

Biologic therapy for inflammatory bowel disease

1 reference

12 December 2020

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease

1 reference

12 December 2020

Methotrexate for the Treatment of Crohn's Disease

1 reference

12 December 2020

Malignancies in rheumatoid arthritis patients treated with cyclosporin A

1 reference

12 December 2020

Peripheral neuropathy in Crohn's disease patients treated with metronidazole

1 reference

12 December 2020

Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy

1 reference

12 December 2020

Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure

1 reference

12 December 2020

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

1 reference

12 December 2020

Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group

1 reference

12 December 2020

Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.

1 reference

12 December 2020

Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis

1 reference

12 December 2020

Short-chain fatty acids in ulcerative colitis.

1 reference

12 December 2020

Acute myeloblastic leukemia following prolonged treatment of Crohn's disease with 6-mercaptopurine

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: results of drug treatment

1 reference

12 December 2020

Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Sulfasalazine. Multiplicity of action

1 reference

12 December 2020

[Treatment of Crohn's disease with azathioprine or 6-mercaptopurine. Retrospective study of 126 cases].

1 reference

12 December 2020

Pancreatitis as an adverse reaction to salicylazosulfapyridine.

1 reference

12 December 2020

5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease

1 reference

12 December 2020

Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

1 reference

12 December 2020

Pancytopenia associated with low dose methotrexate therapy. A regional survey

1 reference

12 December 2020

Methotrexate for inflammatory bowel disease: pharmacology and preliminary results

1 reference

12 December 2020

Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis

1 reference

12 December 2020

Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis

1 reference

12 December 2020

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).

1 reference

12 December 2020

5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis

1 reference

12 December 2020

Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis

1 reference

12 December 2020

Neoral may be as effective as intravenous cyclosporine in the treatment of steroid-resistant ulcerative colitis.

1 reference

12 December 2020

Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials

1 reference

12 December 2020

Immunomodulator therapy of inflammatory bowel disease

1 reference

12 December 2020

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Cyclosporin absorption from microemulsion formulation in liver transplant recipient

1 reference

12 December 2020

The pharmacology and clinical use of methotrexate

1 reference

12 December 2020

Studies on the mechanism of formation of 5-mercapto-1-methyl-4-nitroimidazole, a metabolite of the immunosuppressive drug azathioprine

1 reference

12 December 2020

Fatal myocarditis associated with mesalazine

1 reference

12 December 2020

Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine)

1 reference

12 December 2020

Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study

1 reference

12 December 2020

Acute Pancreatitis Associated with Steroid Therapy

1 reference

12 December 2020

Methotrexate: adverse reactions and major toxicities

1 reference

12 December 2020

Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis

1 reference

12 December 2020

Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies

1 reference

12 December 2020

Suppression of the humoral immune response by mycophenolate mofetil

1 reference

12 December 2020

Treatment of ulcerative colitis with hydrocrotisone enemas: relationship of hydrocortisone absorption, adrenal suppression, and clinical response

1 reference

12 December 2020

Prevention and treatment of osteoporosis in patients with inflammatory bowel disease

1 reference

12 December 2020

Inflammatory bowel disease

1 reference

12 December 2020

Sulfasalazine. Adverse effects and desensitization

1 reference

12 December 2020

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

1 reference

12 December 2020

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

12 December 2020

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

1 reference

12 December 2020

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

1 reference

12 December 2020

The safety of mesalamine in human pregnancy: a prospective controlled cohort study

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: adverse reactions to study drugs

1 reference

12 December 2020

Megaloblastic anaemia associated with sulphasalazine treatment

1 reference

12 December 2020

Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine

1 reference

12 December 2020

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

1 reference

12 December 2020

Inflammatory intermediaries in inflammatory bowel disease

1 reference

12 December 2020

Pharmacokinetics and absolute rectal bioavailability of hydrocortisone acetate in distal colitis

1 reference

12 December 2020

Sulphasalazine treatment during breast feeding

1 reference

12 December 2020

Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine.

1 reference

12 December 2020

Toxic epidermal necrolysis (Leyell's syndrome). A report on four cases with three deaths

1 reference

12 December 2020

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

1 reference

12 December 2020

Topical treatment of ulcerative colitis.

1 reference

12 December 2020

Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease

1 reference

12 December 2020

The relationship between infliximab treatment and lymphoma in Crohn's disease

1 reference

12 December 2020

The mechanism of action of cyclosporin A and FK506

1 reference

12 December 2020

A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.

1 reference

12 December 2020

Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis

1 reference

12 December 2020

Corticosteroids: clinical pharmacology and therapeutic use.

1 reference

12 December 2020

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

12 December 2020

Transdermal nicotine for active ulcerative colitis.

1 reference

12 December 2020

Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy

1 reference

12 December 2020

Inflammatory bowel disease and pregnancy

1 reference

12 December 2020

The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine

1 reference

12 December 2020

The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function

1 reference

12 December 2020

A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result

1 reference

12 December 2020

Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease

1 reference

12 December 2020

The treatment of ulcerative colitis in children with alternate-day corticosteroids

1 reference

12 December 2020

Disposition of olsalazine and metabolites in breast milk

1 reference

12 December 2020

Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF)

1 reference

12 December 2020

Mycophenolic acid; an antibiotic from Penicillium brevicompactum Dlerckx

1 reference

12 December 2020

Oxidants and free radicals in inflammatory bowel disease

1 reference

12 December 2020

Low-dose oral methotrexate in refractory inflammatory bowel disease

1 reference

12 December 2020

Nutrition and ulcerative colitis

1 reference

12 December 2020

10.2165/00002018-200023050-00006

Identifiers

DOI

1 reference

PubMed ID

11085348

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

11085348